The Board of Directors of Dr Reddys Laboratories Ltd (DRREDDY) at its meeting held on 14 May 2021, has declared Final Dividend of Rs 25 per equity share. The Board Meeting commenced at 09.00 AM and concluded at 12.05 PM.
Dr Reddys Laboratories Ltd Q4 Result
The company reported a 28 per cent year-on-year decline in consolidated net profit to Rs 554 crore for the quarter ended March 2021. The drugmaker reported 7 per cent year-on-year growth in consolidated revenues to Rs 4,728 crore for the fourth quarter of the last financial year.
Similar Posts
- L&T Technology Services Ltd Declares Final Dividend of Rs 14.5
- DCM Shriram Ltd Declares Final Dividend of Rs 3.8
Dr Reddys Laboratories Ltd Dividend Record Date
The company in its letter has informed the exchanges that it has fixed 12 July 2021 as the Record date. Payment of dividend will be made to those shareholders whose names appear as Beneficial Owners as at the close of business hours on Monday, i.e. 12 July 2021.
Moreover, to receive dividend, you must have shares in your demat account on record date. Hence, you should buy shares before ex-dividend date. Note – If you buy shares on ex-dividend date, you will not be eligible to receive dividend. Bookmark our website for latest and upcoming dividend announced by companies in 2021.
Above all, here is the copy of statement, the company has sent to the exchanges:
We would also like to inform that the Board of Directors have recommended a final dividend of Rs.
25/- (500%) per equity share of Rs. 5/- face value for the financial year 2020-21. The dividend will be
paid on or after five days from the date of declaration of the final dividend by the shareholders.
Important Dates
- Company – Dr Reddys Laboratories Ltd
- Script Name – DRREDDY (NSE) and 500124 (BSE)
- Dividend Amount – 25 Rs Per Share
- Dividend Type – Final
- Ex-Dividend Date – 9 July 2021
- Record Date – 12 July 2021
- Payment Date – 27 August 2021
Also, you can find more information about Dr Reddys Laboratories Ltd on National Stock Exchange and Moneycontrol – Dr Reddys Laboratories Ltd manufactures generic medicines with business spread across India, Russia, US and Germany as well as Proprietary Products which includes NCE research, biologics business and differentiated formulations conducted in the US.
